IV catheter placement is the most common invasive hospital procedure worldwide.1,2 Up to 90% of hospitalized patients require IV therapy, over 95% of these devices are peripheral IV catheters (PIVC).2 With every PIVC insertion attempt, healthcare workers (HCWs) risk exposure to patient blood.3-5 Needlestick injuries (NSIs) and blood leakage may expose HCWs to more than 30 dangerous pathogens that can be present in human blood, including hepatitis B, C and HIV.6 The BD Insyte Autoguard™ BC Shielded IV Catheter with blood control technology is designed to provide HCWs protection from needlestick injuries and blood exposure.
true
BD Insyte Autoguard™ BC Shielded IV Catheter with Blood Control Technology
Confidently keep blood in its place — away from you and your patients.
- Overview
- Products & Accessories
- EIFU & Resources
Confidently keep blood in its place—away from you and your patients.
true
Making IV access more convenient
No need to apply venous compression during initial insertion with BD Insyte Autoguard™ BC Shielded IV Catheters.7 BD Insyte Autoguard™ BC Shielded IV Catheters with blood control technology are designed to stop the flow of blood from the catheter hub until the initial luer connection is made.
Making IV access safer for healthcare workers
BD Insyte Autoguard™ BC Shielded IV Catheters with blood control technology demonstrated a 95% reduction in the risk of blood exposure.7*^
Making IV access less risky
In a healthy human study, 98% of clinicians indicated they felt no risk of blood exposure during insertion when using BD Insyte Autoguard™ BC Shielded IV Catheters.7*^
Making IV access more successful
BD Instaflash™ Needle Technology incorporates a notched needle, which was clinically demonstrated to improve first-attempt insertion success.8-9
* Compared to a non-blood control catheter
^ In a healthy human study
- Helm RE, Klausner JD, Klemperer JD, et al. Accepted but unacceptable: peripheral IV catheter failure: Infus Nurs Society. 2015;38(3):189-203.
- iData Research Inc. Global Market Report Suite for Vascular Access Devices and Accessories. 2020.
- Tarantola A, Abiteboul D, Rachline A. Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases. Am J Infect Control. 2006:34:367-375.
- Haeseler G, Hildebrand M, Fritscher J. Efficacy and ease of use of an intravenous catheter designed to prevent blood leakage: a prospective observational trial. JVA. 2015;16(3):233-236. doi: 10.5301/jva.5000334.
- Jagger J Perry J, Parker G, et al. Survey results: Blood exposure risk during peripheral IV catheter insertion and removal. Nursing. 2011;41(12):45-49. doi:10.1097/01.NURSE.0000407678.81635.62
- European Biosafety Network. Prevention of Sharps Injuries in the Hospital and Healthcare Sector. European Biosafety Network Implementation Guidance Toolkit for EU Council Directive. 2010/32/EU. January 2013. Available at www.europeansafetynetwork.eu (accessed May 2017).
- Onia R, Eshun-Wilson I, Arce C, et al. Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure. CMRO. 2011;27(7):1339-1346.
- van Loon FHJ, Timmerman R, den Brok GPH, Korsten EHM, Dierick-van Daele ATM, Bouwman ARA. The impact of a notched peripheral intravenous catheter on the first attempt success rate in hospitalized adults: block-randomized trial. JVA. 2021 doi: 10.1177/1129729821990217.
- Seetharam AM, Raju U, Suresh K. A randomized controlled study to compare first stick success with Instaflash technology: The FIRSST study. JVA. 2022 doi:10.1177/11297298221080369.
true
BD-14385 (02/24)
Sort by:
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
true
BD Insyte Autoguard™ BC Training
Find our training resources to help improve your clinical practices as part of our goal of advancing the world of health.
Learn More
true
true